Results 181 to 190 of about 16,409 (241)

Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population

, 2012
Dalal AA, Manan Shah, D amp Souza AO, Sameer Chaudhari, Glenn Crater   +4 more
openalex   +1 more source

Additional file 4: Table S1. of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

, 2015
Dave Singh, Sally Worsley, Chang-Qing Zhu, Liz Hardaker, Alison Church   +4 more
openalex   +1 more source

Changes in Inhaled Steroid Dispensing to Children After Withdrawal of Brand-Name Fluticasone Propionate.

JAMA
Chua KP, Volerman A, Conti RM.
europepmc   +1 more source

Influence of budesonide and fluticasone propionate in the anti-osteoporotic potential in human bone marrow-derived mesenchymal stem cells via stimulation of osteogenic differentiation. [PDF]

Heliyon
Sumague TS, Niazy AA, Lambarte RNA, Nafisah IA, Gusnanto A.   +4 more
europepmc   +1 more source

Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis

, 2016
Doerthe A. Andreae, Matthew G Hanna, Margret S. Magid, Stefano Malerba, Michael H. Andreae, Emilia Bagiella, Mirna Chehade   +6 more
openalex   +2 more sources

Retracted: Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD). [PDF]

Emerg Med Int
International EM.
europepmc   +1 more source

Efficacy and safety of combination ointment "fluticasone propionate 0.005% plus mupirocin 2.0%" for the treatment of atopicdermatitis with clinical suspicion of secondary bacterial infection: anopen label uncontrolled study

, 2005
Kunal Khobragade
openalex   +1 more source

Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells. [PDF]

J Asthma Allergy, 2020
Berger WE, Bachert C, Allara R, Koltun A, Kopietz F, Maus JG, D'Addio AD.   +6 more
europepmc   +1 more source

Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database

, 2018
Steven Lehrer, Peter H. Rheinstein
openalex   +2 more sources